These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372 [TBL] [Abstract][Full Text] [Related]
3. Azapeptides as inhibitors and active site titrants for cysteine proteinases. Xing R; Hanzlik RP J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822 [TBL] [Abstract][Full Text] [Related]
4. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases. Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871 [TBL] [Abstract][Full Text] [Related]
5. Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B. Gour-Salin BJ; Lachance P; Plouffe C; Storer AC; Ménard R J Med Chem; 1993 Mar; 36(6):720-5. PubMed ID: 8459399 [TBL] [Abstract][Full Text] [Related]
6. Demonstration that 1-trans-epoxysuccinyl-L-leucylamido-(4-guanidino) butane (E-64) is one of the most effective low Mr inhibitors of trypsin-catalysed hydrolysis. Characterization by kinetic analysis and by energy minimization and molecular dynamics simulation of the E-64-beta-trypsin complex. Sreedharan SK; Verma C; Caves LS; Brocklehurst SM; Gharbia SE; Shah HN; Brocklehurst K Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):777-86. PubMed ID: 8670152 [TBL] [Abstract][Full Text] [Related]
7. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid. Schirmeister T J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963 [TBL] [Abstract][Full Text] [Related]
8. E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group. Schaschke N; Assfalg-Machleidt I; Machleidt W; Turk D; Moroder L Bioorg Med Chem; 1997 Sep; 5(9):1789-97. PubMed ID: 9354234 [TBL] [Abstract][Full Text] [Related]
9. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases. Barrett AJ; Kembhavi AA; Hanada K Acta Biol Med Ger; 1981; 40(10-11):1513-7. PubMed ID: 7044005 [TBL] [Abstract][Full Text] [Related]
10. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives. Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors. Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922 [TBL] [Abstract][Full Text] [Related]
12. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases. Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139 [TBL] [Abstract][Full Text] [Related]
13. Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length. Hall A; Abrahamson M; Grubb A; Trojnar J; Kania P; Kasprzykowska R; Kasprzykowski F J Enzyme Inhib; 1992; 6(2):113-23. PubMed ID: 1284427 [TBL] [Abstract][Full Text] [Related]
15. Proteinases in renal cell death. Yang X; Schnellmann RG J Toxicol Environ Health; 1996 Jul; 48(4):319-32. PubMed ID: 8691504 [TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes. Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396 [TBL] [Abstract][Full Text] [Related]
17. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease. Chan VJ; Selzer PM; McKerrow JH; Sakanari JA Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):113-7. PubMed ID: 10229665 [TBL] [Abstract][Full Text] [Related]
18. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors. Schaschke N; Assfalg-Machleidt I; Machleidt W; Moroder L FEBS Lett; 1998 Jan; 421(1):80-2. PubMed ID: 9462845 [TBL] [Abstract][Full Text] [Related]
19. Interdependency of sequence and positional specificities for cysteine proteases of the papain family. Nägler DK; Tam W; Storer AC; Krupa JC; Mort JS; Ménard R Biochemistry; 1999 Apr; 38(15):4868-74. PubMed ID: 10200176 [TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors. Meara JP; Rich DH J Med Chem; 1996 Aug; 39(17):3357-66. PubMed ID: 8765519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]